FLT3 and acute myeloid leukemia: FLT3 mutations can be classified into point mutations in the Tyrosine Kinase Domain (TKD) and Internal Tandem Duplications (ITD) in the juxtamembrane domain with each accounting for 5 and 25% of patients with AML, respectively.